Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Intuitive Surgical Community
NasdaqGS:ISRG Community
3
Narratives
written by author
14
Comments
on narratives written by author
225
Fair Values set
on narratives written by author
Create a narrative
Intuitive Surgical
Popular
Undervalued
Overvalued
Community Investing Ideas
Intuitive Surgical
TO
Tokyo
Community Contributor
From Battle Field to Robotic Surgery
Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making minimally invasive surgery more precise and efficient.
View narrative
US$400.91
FV
23.1% overvalued
intrinsic discount
12.02%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
34
users have followed this narrative
15 days ago
author updated this narrative
Intuitive Surgical
UN
Unike
Community Contributor
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Catalysts Most Immediate Catalysts (1–2 Years) Increased Adoption of Robotic Surgery: Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times. Expansion into more surgical specialties (e.g., gynecology, urology, general surgery) drives near-term revenue growth.
View narrative
US$325.55
FV
51.6% overvalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
27 days ago
author updated this narrative
Intuitive Surgical
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
Investments In R&D And Manufacturing Optimization Will Improve Operating Efficiencies
Key Takeaways The da Vinci 5 platform's expansion and global clearances are set to enhance revenue growth through increased placements and upgrades. Strategic acquisitions and investments in R&D are expected to improve market reach, operating efficiencies, and reduce margin dilution, boosting earnings.
View narrative
US$619.74
FV
20.4% undervalued
intrinsic discount
14.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
120
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
ISRG
ISRG
Intuitive Surgical
Your Fair Value
US$
Current Price
US$493.60
18.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
15b
2015
2018
2021
2024
2025
2027
2030
Revenue US$14.7b
Earnings US$4.1b
Advanced
Set Fair Value